NextTrial Launches NextTrial One: A Cutting-Edge Integrated Platform for Life Sciences
NextTrial has officially unveiled NextTrial One, an innovative unified intelligence platform poised to transform data-driven decision-making in the life sciences sector. Announced on January 14, 2026, this AI-enhanced platform aims to streamline innovation across pharmaceutical, biotech, and contract research organizations (CROs) by consolidating clinical, safety, and regulatory data into a cohesive framework, delivering real-time insights and advanced analytics.
"In an era marked by the increasing complexities of research, safety, and regulatory compliance, NextTrial One offers a comprehensive data and AI foundation that connects teams, processes, and enterprise data," stated Sharad Prakash, Founder and CEO of NextTrial. He emphasized the platform’s mission to expedite decision-making, ensure compliance, and maximize data utility.
Key Features of NextTrial One:
-
Study 360: Clinical Trial Intelligence: This solution combines operational, clinical, and real-world data into a singular source of truth, designed to accelerate clinical trial initiation, enhance patient recruitment strategies, and provide continuous trial performance monitoring with intelligent dashboards and predictive analytics.
-
Total Safety Intelligence: This feature modernizes drug safety oversight by integrating case intake, quality control, signal detection, and risk management into a unified framework. It aids organizations in detecting risks early, enhancing patient safety, and bolstering audit readiness.
-
Regulatory Navigator: This solution simplifies global regulatory operations by tracking emerging regulations, automating compliance checks, and managing submissions with precision, turning regulatory data into actionable intelligence.
NextTrial One aims to eliminate data silos and champion a "connect once, use everywhere" approach to modern decision-making. The platform accommodates multi-source data ingestion and offers AI/ML-driven analytics, allowing organizations to develop bespoke intelligence solutions.
"This launch signifies a pivotal moment in our journey to create a foundational digital infrastructure for next-generation life sciences innovation," Prakash concluded.
Headquartered in Orlando, Florida, with regional offices in New Jersey and Bangalore, NextTrial is dedicated to reshaping how life sciences organizations utilize AI-driven intelligence to accelerate clinical development, enhance safety protocols, and improve compliance processes.
